Kenneth C. Cassidy - Concepedia

Author

Kenneth C. Cassidy

Also Known As

K C Cassidy, K Cassidy, K. C. CASSIDY, K. Cassidy, K.C. Cassidy, KENNETH CASSIDY, Kenneth C Cassidy, Kenneth C. Cassidy, Kenneth Cassidy

Publications

588

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Windsor

About

Kenneth C. Cassidy is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	154
2	Biochemistry	6	6	209
3	Natural Sciences	4	4	179
4	Engineering	3	3	162
5	Health Sciences	1	1	18

Kenneth C. Cassidy

Publications

512

Citations

H-Index

Page 1

	Year	Citations
Total synthesis of streptonigrone Dale L. Boger, Kenneth C. Cassidy, Shinsuke Nakahara Journal of the American Chemical Society AltmetricsStreptonigronedale L. BogerEngineeringInformationAltmetric Attention Score	1993	78
Diastereoselective alkylation guided by electrophile-nucleophile .pi.-interactions John M. McIntosh, Randy K. Leavitt, Pratibha Mishra, The Journal of Organic Chemistry AltmetricsEngineeringChemical AnalysisBiochemistryDonut Icon	1988	74
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm Prabhakar K. Jadhav, Matthew A. Schiffler, Kostas Gavardinas, ACS Medicinal Chemistry Letters Molecular DockingMedicinal ChemistryPharmaceutical ChemistryDrug TargetBiochemistry	2014	65
Disposition and Metabolism of LY2452473, a Selective Androgen Receptor Modulator, in Humans Ping Yi, Jessica Rehmel, Kenneth C. Cassidy, Drug Metabolism and Disposition	2012	40
Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure Maciej J. Zamek‐Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Drug Metabolism and Disposition	2013	39
Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats Xin Zhou, L. Rougée, David W. Bedwell, Drug Metabolism and Disposition	2016	27
Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury Bryan H. Norman, Matthew J. Fisher, Matthew A. Schiffler, Journal of Medicinal Chemistry Medicinal ChemistryReactive MetabolitesBiochemistry2-Aminoimidazole-based InhibitorsMedicine	2018	26
Considerations for Human <scp>ADME</scp> Strategy and Design Paradigm Shift(s) – An Industry White Paper Graeme Young, Douglas K. Spracklin, Alexander D. James, Clinical Pharmacology & Therapeutics	2022	26
Abstract CT153: Pharmacokinetic drug interactions between abemaciclib and CYP3A inducers and inhibitors Palaniappan Kulanthaivel, Daruka Mahadevan, P. Kellie Turner, Cancer Research Breast OncologyHealthy SubjectsPharmacotherapySystem PharmacologyPre-clinical Pharmacology	2016	21
Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches. Jeffrey Stevens, Jessica L. Fayer, Kenneth C. Cassidy PubMed BiochemistryRg 12525Vivo ApproachesLiver PhysiologyPhysiology	2001	18

Page 1